Form Type: 4

SEC EDGAR Link
Accession Number:0001209191-21-012215
Date:2021-02-16
Issuer: ADVERUM BIOTECHNOLOGIES, INC. (ADVM)
Original Submission Date:

Reporting Person:

THEDINGA ANGELA
C/O ADVERUM BIOTECHNOLOGIES, INC.
800 SAGINAW DRIVE REDWOOD CITY, CA 94063

Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
Title of SecurityTransaction Date2a. Deemed Execution Date Transaction CodeSharesAcquired or DisposedPrice per share 5. Amount of Securities Beneficially Owned Following Reported Transaction 6. Ownership Form Direct or IndirectNature of Indirect Ownership
Derivative Securities Acquired, Disposed of, or Beneficially Owned
(e.g., puts, calls, warrants, convertible securities
Title of Derivative Security Conversion or Exercise Price of Derivative Security Transaction Date Deemed Execution Date Transaction Code Number of Derivative Securities Acquired (A) or Disposed of (D) Date ExercisableExpiration Date Title and Amount of Securities Underlying Derivative Security Price of Derivative Security Number of derivative Securities Beneficially Owned Following Reported Transaction(s) Ownership Form: Direct (D) or Indirect (I) Nature of Indirect Beneficial Ownership
STOCK OPTION (RIGHT TO BUY) 13.44 2021-02-16 deemed execution date A 250,000 (a) 2031-02-15 common stock 250,000 $13.44 250,000 direct
Footnotes
IDfootnote
f1 twenty-five percent (25%) of the total number of shares subject to the option vest and become exercisable on the first anniversary of february 16, 2021 (the "vesting commencement date"), and 1/48 of the total number of shares subject to the option vest and become exercisable each month thereafter, such that all of the shares subject to the option shall become vested and exercisable as of the fourth anniversary of the vesting commencement date, subject to the reporting person's continued service with the issuer on each such vesting date.
WhaleWisdom Logo

Elevate your investments